Jump to content
AMCP Learn
Search
Open menu
Cart
AMCP Learn login
Register
Bookmark/Search this post
Facebook
X
LinkedIn
Forward
Home
Catalog
Training Programs
Help
Contact Us
FAQ
You are here
Home
Search
(F3) Mission Possible: How Integrated Medical & Pharmacy Benefits Can Improve Specialty Drug Management
(L3) An Enterprise Solution for Mental Health Parity Compliance
(W3) Patient Experience Data in Managed Care Pharmacy Decision Making: Barriers, Opportunities, and Practical Strategies for Managed Care Pharmacists
(K1) 2025-2026 Health Care and Pharmaceutical Marketplace Trends
Wednesday, 4/15 - Sessions from 10:15-11:30am
(F4) Advancing Patient-Centered Care in Narcolepsy Type 1: Integrating the Latest Evidence, Guidelines, and Treatment Innovations
(D4) Digesting the Disruption: Biosimilars, Benefits, and Barriers in IBD Care
(M4) Drug Pipeline: Traditional Pharmaceuticals (Brands and Generics) and Biosimilars
(R4) Leveraging Mortality Data for Real-World Evidence in Managed Care: Challenges and Potential Solutions
(W4) Unlocking AI’s Potential in Managed Care: An Actionable Roadmap
Wednesday, 4/15 - Sessions from 2:45-4:00pm
(D5) Implementing a Comprehensive Asthma Care Management Program to Achieve Quality Improvement and Positive Health Outcomes
(F5) Diving into Data: An Introduction to Managed Care Research
(L5) From MFP to MFN — Price Controls, Politics & the Rebate Reckoning
(M5) Mind the Gap: Rethinking Oncology Management Before It’s Too Late
Wednesday, 4/15 - Sessions from 4:15-5:15pm
(D6) The Future of Metabolic Health in Managed Care: Population Risk and Financial Impact
(L6) State Legislative and Regulatory Update
(K2) Unpacking the Data: The Application and Interpretation of Real-World Evidence in GLP-1 Obesity Treatment
(K3) Emerging Specialty Pharmaceuticals: Current Development Landscape and Why It Matters
Mission Possible: How Integrated Medical & Pharmacy Benefits Can Improve Specialty Drug Management
Advancing Patient-Centered Care in Narcolepsy Type 1: Integrating the Latest Evidence, Guidelines, and Treatment Innovations
RWE in Action: Using the AMCP RWE Standards to Facilitate Formulary Decisions
From MFP to MFN — Price Controls, Politics & the Rebate Reckoning
AMCP 2026 - Federal Legislative and Regulatory Update
Pages
« first
‹ previous
1
2
Search
Home
Catalog
Training Programs
Help
Contact Us
FAQ